Ana Combarro-Serrano
Santander, CB, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Window of opportunity with abatacept in Rheumatoid arthritis-associated interstitial lung disease: A multicentre study of 526 patients.
Journal: European journal of internal medicine
Published: April 01, 2026
Validation of screening criteria for interstitial lung disease in rheumatoid arthritis in routine clinical practice: the VAR-EPIDSER study.
Journal: RMD open
Published: March 10, 2026
A New Approach for Achieving Earlier and More Accurate Diagnosis of Connective Tissue Disease-Related Interstitial Lung Disease: TGFB and PDGFA as Novel Promising Biomarkers.
Journal: International journal of molecular sciences
Published: September 30, 2025
Progressive interstitial lung disease associated with rheumatoid arthritis and abatacept: data from a multicentre cohort of 526 patients.
Journal: Rheumatology (Oxford, England)
Published: August 26, 2025
Baricitinib in rheumatoid arthritis-interstitial lung disease: a literature review and national multicentre study of 72 patients.
Journal: Rheumatology (Oxford, England)
Published: January 22, 2025
Real-world evidence of the antifibrotic nintedanib in rheumatoid arthritis-interstitial lung disease. National multicenter study of 74 patients.
Journal: Seminars in arthritis and rheumatism
Published: January 07, 2025
Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients.
Journal: Seminars in arthritis and rheumatism
Published: March 04, 2024
The usefulness of 18F-FDG-PET/CT in detecting musculoskeletal and vascular involvement in patients with polymyalgia rheumatica receiving glucocorticoids.
Journal: European journal of internal medicine
Published: July 26, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026